In this report, the anti-fibrotic activity and the mechanism of action for new ATP-competitive PRS inhibitor T-3833261 on TGF-β-induced fibrotic assay were compared with those of HF in vitro. The gene discussed is TGFB1; the disease is hydrops fetalis.